Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Adolescent (1)
- Anabolic Androgenic Steroids (1)
- Body Dysmorphic Disorders (1)
- Efficacy (1)
- Endocrine (1)
-
- Female (1)
- Mental Health (1)
- Myo-inositol (1)
- Neuroimaging (1)
- PCOS (1)
- Polycystic Ovary Syndrome (1)
- Psychosocial Intervention (1)
- Relapse (1)
- Scoping review (1)
- Self-administration (1)
- Sex differences (1)
- Sex hormones (1)
- Substance Use Disorder (SUD) (1)
- Substance-Related Disorders (1)
- Teenager (1)
- Treatment outcome (1)
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Chemicals and Drugs
Investigating The Efficacy Of Myo-Inositol In Adolescents With Polycystic Ovary Syndrome: A Scoping Review, Mariam Sharobeem
Investigating The Efficacy Of Myo-Inositol In Adolescents With Polycystic Ovary Syndrome: A Scoping Review, Mariam Sharobeem
Rowan-Virtua Research Day
Polycystic ovary syndrome (PCOS) affects approximately 6 to 13% of adolescent girls in the United States.6 PCOS poses difficulty with diagnosing and treatment with adolescents as its symptoms are heterogenous and are often rationalized with other diagnoses. Key diagnostic features of PCOS include irregular menstruation, infertility, obesity, hirsutism, increased risk of diabetes mellitus, hypertension, lipid abnormalities and metabolic syndrome.12 Currently, there are no pharmacological therapies approved by the FDA to treat PCOS.5 Alternatives include pharmacological management of symptoms with medications like combined oral contraceptive pills, metformin and anti-obesity agents.6 Recently, more discussion about the lack of PCOS treatment has been …
Editorial: Sex Differences In The Neurobiology Of Drug Relapse Vulnerability, Daniel F Manvich, Jessica A Loweth, Wendy J Lynch, Jayme R Mcreynolds
Editorial: Sex Differences In The Neurobiology Of Drug Relapse Vulnerability, Daniel F Manvich, Jessica A Loweth, Wendy J Lynch, Jayme R Mcreynolds
Rowan-Virtua School of Osteopathic Medicine Faculty Scholarship
No abstract provided.
Body Dysmorphic-Induced Androgenic Anabolic Steroids Usage And Its Association With Mental Health Outcomes: A Systematic Review, Ahmed Gawash, Hasan Zia, David Lo
Body Dysmorphic-Induced Androgenic Anabolic Steroids Usage And Its Association With Mental Health Outcomes: A Systematic Review, Ahmed Gawash, Hasan Zia, David Lo
Rowan-Virtua Research Day
This systematic review on body dysmorphic disorder (BDD), anabolic-androgenic steroid (AAS) use, and mental health outcomes aim to examine the relationship between them. While looking at prior research, it has been suggested that individuals with BDD may be more likely to abuse AAS due to their preoccupation with appearance but, unfortunately, AAS use may worsen mental health issues in this population and exacerbate the issue. This systematic review will also discuss treatments that will help mitigate the effects of AAS on individuals with BDD. The review will include only published literature from a variety of databases such as PubMed, Scopus, …